162 related articles for article (PubMed ID: 17048981)
1. How important is diabetes as a risk factor for cardiovascular and other diseases in older adults?
Kengne AP; Patel A
PLoS Med; 2006 Oct; 3(10):e424. PubMed ID: 17048981
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control and cardiovascular mortality.
Riddle MC
Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
[TBL] [Abstract][Full Text] [Related]
3. Diabetes management: More than just cardiovascular risk?
Zimmerman RS; Pantalone KM
Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217
[No Abstract] [Full Text] [Related]
4. [Early insulin therapy reduces cardiovascular risk].
Med Monatsschr Pharm; 2007 Apr; 30(4):160-1. PubMed ID: 17484451
[No Abstract] [Full Text] [Related]
5. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Drug Therapy of Diabetes Mellitus to Prevent Complications].
Inagaki N
Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1912-6. PubMed ID: 30160897
[No Abstract] [Full Text] [Related]
6. [Anti-diabetic therapy and cardiovascular disease].
Mannucci E
G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):3s-4. PubMed ID: 27030117
[No Abstract] [Full Text] [Related]
7. Strategies for the development of new PPAR agonists in diabetes.
Cavender MA; Nicholls SJ; Lincoff AM
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S32-7. PubMed ID: 20489419
[TBL] [Abstract][Full Text] [Related]
8. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
[TBL] [Abstract][Full Text] [Related]
9. Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
Chen J; Raymond K
Vasc Health Risk Manag; 2008; 4(6):1265-72. PubMed ID: 19337540
[TBL] [Abstract][Full Text] [Related]
10. [What is really an optimal treatment in type 2 diabetes? New studies call for reflection].
Nilsson PM; Eliasson B
Lakartidningen; 2008 Apr 2-8; 105(14):985-6. PubMed ID: 18478745
[No Abstract] [Full Text] [Related]
11. Draft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity?
Khunti K; Davies MJ; Marx N; Buse JB
Lancet Diabetes Endocrinol; 2020 Oct; 8(10):810-811. PubMed ID: 32946819
[No Abstract] [Full Text] [Related]
12. The global challenge of diabetes.
Lancet; 2008 May; 371(9626):1723. PubMed ID: 18502275
[No Abstract] [Full Text] [Related]
13. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
14. Role of risk factors in complications of diabetes mellitus.
Dupree EA; Meyer MB
Am J Epidemiol; 1980 Jul; 112(1):100-12. PubMed ID: 6994490
[No Abstract] [Full Text] [Related]
15. Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.
Spallarossa P; Barsotti A; Cordera R; Ghigliotti G; Maggi D; Brunelli C
J Endocrinol Invest; 2004 May; 27(5):485-95. PubMed ID: 15279085
[TBL] [Abstract][Full Text] [Related]
16. Therapy of early diabetes. The University Group Diabetes Program.
Prout TE
Adv Metab Disord; 1973; 2():Suppl 2:501-20. PubMed ID: 4720381
[No Abstract] [Full Text] [Related]
17. Risk modification for diabetic patients. Are other risk factors treated as diligently as glycemia?
Shah BR; Mamdani M; Jaakkimainen L; Hux JE
Can J Clin Pharmacol; 2004; 11(2):e239-44. PubMed ID: 15557673
[TBL] [Abstract][Full Text] [Related]
18. [Anti-diabetic therapy and cardiovascular risk].
Mannucci E
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
[No Abstract] [Full Text] [Related]
19. Role of oral agents in improving cardiovascular prognosis in diabetes mellitus.
Hirsch RL
Mayo Clin Proc; 2010 Jan; 85(1):99; author reply 99-101. PubMed ID: 20042566
[No Abstract] [Full Text] [Related]
20. Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification.
Wong K; Glovaci D; Malik S; Franklin SS; Wygant G; Iloeje U; Kan H; Wong ND
J Diabetes Complications; 2012; 26(3):169-74. PubMed ID: 22502939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
